Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study
- 28 May 2018
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 102 (1), 61-70
- https://doi.org/10.1016/j.ijrobp.2018.05.046
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- The significance of combining radiotherapy with chemotherapy for early stage extranodal natural killer/T-cell lymphoma, nasal type: a systematic review and meta-analysisLeukemia & Lymphoma, 2013
- A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal typeJournal of Hematology & Oncology, 2013
- Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for stage I-II natural killer/T-cell lymphoma nasal type: dosimetric and clinical resultsRadiation Oncology, 2013
- SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study GroupBlood, 2012
- Distribution of Lymphoid Neoplasms in ChinaAmerican Journal of Clinical Pathology, 2012
- Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institutionDiagnostic Pathology, 2011
- Unfavorable prognosis of elderly patients with early-stage extranodal nasal-type NK/T-cell lymphomaAnnals of Oncology, 2011
- Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescentsBlood, 2009
- Extranodal NK / T‐cell lymphoma, nasal type: New staging system and treatment strategiesCancer Science, 2009
- Extranodal nasal type NK/T-cell Lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapyEuropean Journal of Cancer, 2005